Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Biofrontera Inc BFRIW


Primary Symbol: BFRI

Healthcare Drug Manufacturers - Specialty & Generic
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with... see more

Current News (NDAQ:BFRI)

Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® PDT in Superficial Basal Cell Carcinoma

GlobeNewswire 4 days ago

Biofrontera Announces Positive Results in Phase 3 Study of Ameluz® PDT for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint

GlobeNewswire 6 days ago

Biofrontera Inc. Announces Record Preliminary Fourth Quarter 2025 Revenues between $17.0 Million and $17.5 Million, Representing Approximately 35% Year-Over-Year Growth

GlobeNewswire January 13, 2026

Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones

GlobeNewswire January 8, 2026

Biofrontera Inc. Completes Transfer of Ameluz® and RhodoLED® FDA approval and Associated Intellectual Property Portfolio

GlobeNewswire December 18, 2025

Last Patient Completes Biofrontera's Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities

GlobeNewswire December 4, 2025

Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT

GlobeNewswire December 2, 2025

Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update

GlobeNewswire November 13, 2025

Biofrontera Inc. announces sale of license to Xepi® Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M

GlobeNewswire November 7, 2025
View More News ››

Opinion & Analysis (NDAQ:BFRI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:BFRI)

BFRI....those support level got whacked

Now support is at $1.17
Iseneschal - October 31, 2024

BFRI.... Crucial support at $1.55

has to hold and rally or next support is $1.45 Me no position....scalped the maddapakka all the way from $1.14 to $2 LoL
Iseneschal - October 31, 2024

BFRI..... I smell a financing

Be careful
Iseneschal - October 31, 2024

Biofrontera Inc. (NASDAQ:BFRI): Significant Cost Savings and

http://beyondspx.com/2024/08/02/biofrontera-inc-nasdaqbfri-significant-cost-savings-and-financing-provide-path-to-profitability/
MikeTester - August 3, 2024

BFRI ..... Up on low volume.....

Everyone wants some "Rights".....why not !!!!!!!!!!!
Iseneschal - October 18, 2022

BFRI .... Latest News Release

Biofrontera Inc. Adopts Limited Duration Shareholder Rights Plan 2022-10-14 05:40 ET - News Release WOBURN, Mass., Oct. 14, 2022...
Iseneschal - October 17, 2022
View more Bullboard ››

AE Fuels Corporation

AE Fuels Corporation

AE Fuels Corporation (TSXV: AEF) is a battery materials company focused on the extraction and purification of minerals ...
View More »

Podcasts